Boston Scientific (BSX) Inventory Average (2009 - 2026)

Boston Scientific (BSX) has 18 years of Inventory Average data on file, last reported at $3.0 billion in Q1 2026.

• For the quarter ending Q1 2026, Inventory Average rose 6.75% year-over-year to $3.0 billion; the trailing twelve-month figure through Mar 2026 stood at $3.0 billion (up 6.75% YoY), and the FY2025 full-year result was $2.9 billion, up 8.67% from the prior year.
• Inventory Average advanced to $3.0 billion in Q1 2026, from $2.9 billion in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $3.0 billion in Q1 2026 to a low of $1.7 billion in Q1 2022.
• A 5-year average of $2.4 billion and a median of $2.5 billion in 2024 frame the typical range for Inventory Average.
• Across the five-year window, Inventory Average jumped 33.73% in 2023 and gained 5.41% in 2025, its largest moves.
• Tracing BSX's Inventory Average over 5 years: stood at $1.8 billion in 2022, then soared by 33.73% to $2.4 billion in 2023, then rose by 13.81% to $2.8 billion in 2024, then advanced by 5.41% to $2.9 billion in 2025, then gained by 3.34% to $3.0 billion in 2026.
• Business Quant data shows BSX's Inventory Average at $3.0 billion in Q1 2026, $2.9 billion in Q4 2025, and $2.9 billion in Q3 2025.